DaVita Inc. (DVA)
NYSE: DVA
· Real-Time Price · USD
140.87
-0.68 (-0.48%)
At close: May 01, 2025, 12:09 PM
-0.48% (1D)
| Bid | 140.79 |
| Market Cap | 10.83B |
| Revenue (ttm) | 12.82B |
| Net Income (ttm) | 936.34M |
| EPS (ttm) | 10.73 |
| PE Ratio (ttm) | 13.13 |
| Forward PE | 10.89 |
| Analyst | Hold |
| Ask | 140.94 |
| Volume | 197,815 |
| Avg. Volume (20D) | 1,007,706 |
| Open | 140.64 |
| Previous Close | 141.55 |
| Day's Range | 138.67 - 142.37 |
| 52-Week Range | 131.27 - 179.60 |
| Beta | 1.04 |
About DVA
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and manag...
Industry Medical - Care Facilities
Sector Healthcare
IPO Date Oct 31, 1995
Employees 76,000
Stock Exchange NYSE
Ticker Symbol DVA
Website https://www.davita.com
Analyst Forecast
According to 5 analyst ratings, the average rating for DVA stock is "Hold." The 12-month stock price forecast is $169, which is an increase of 19.97% from the latest price.
Stock ForecastsNext Earnings Release
DaVita Inc. is scheduled to release its earnings on May 12, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-11.09%
DaVita shares are trading lower after the company ...
Unlock content with
Pro Subscription
2 months ago
+2.94%
DaVita shares are trading lower. The company reported Q4 financial results.
